Showing posts sorted by date for query VACCINATION. Sort by relevance Show all posts
Showing posts sorted by date for query VACCINATION. Sort by relevance Show all posts

Monday, June 15, 2026

Americans split on fluoridation; opposition by MAHA supporters notable


ADA trusted more than 2-1 over RFK Jr. on health effects of fluoride in drinking water



 




Annenberg Public Policy Center of the University of Pennsylvania

Support for using fluoride in public drinking 

image: 

Annenberg Science and Public Health (ASAPH) Survey Apr. 2026, N=1639, MOE=+/-3.5%

view more 

Credit: Annenberg Public Policy Center





As the debate over the value of adding fluoride to public drinking water percolates in communities across the nation, a new nationally representative survey from the Annenberg Public Policy Center (APPC) of the University of Pennsylvania finds Americans sharply divided over the use of fluoride in public drinking water.

The new findings come amid renewed attention to fluoridation following critical remarks by Health and Human Services Secretary Robert F. Kennedy Jr., legal and regulatory developments, and renewed scientific debate over the health effects of different levels of fluoride exposure.

Fluoride, a mineral that naturally occurs in water and food, is commonly added to dental products such as toothpaste and mouthwash. Most major U.S. cities fluoridate their drinking water. But concerns have arisen that for some pregnant women and children, “the combined total intake of fluoride may exceed safe amounts.”

For decades, the Centers for Disease Control and Prevention (CDC) has promoted community water fluoridation as a safe, cost-effective way to reduce tooth decay, calling it a major contributor to declining cavity rates in the 20th century. The agency has said that fluoridated water saves billions annually in avoided dental treatment costs.

However, on April 6, 2025, the U.S. Environmental Protection Agency (EPA) announced that it will be reviewing “new science on fluoride in drinking water.” That day, RFK Jr. announced that he planned to “tell the Centers for Disease Control and Prevention (CDC) to stop recommending fluoridation in communities nationwide” and “said he’s assembling a task force of health experts to study the issue and make new recommendations.” In a news story, the Associated Press noted that “Kennedy cannot order communities to stop fluoridation, but he can direct the CDC to stop recommending it and work with the EPA to change the allowed amount.”

Highlights

APPC’s Annenberg Science and Public Health Survey (ASAPH) survey, conducted April 14-28, 2026, among 1,639 U.S. adults, finds that:

  • 43% of U.S. adults favor the use of fluoride in public drinking water while 26% oppose it and 30% neither favor nor oppose it.
  • When asked whether they’d favor or oppose fluoridation of the drinking water in their community, if the community was deciding whether to do so, 43% would favor fluoridation and 23% would oppose it, with 34% saying neither favor nor oppose.
  • Self-identified supporters of the MAHA movement are more likely to oppose than favor (41% vs. 26%) adding fluoride to their community’s drinking water. Among those who do not support MAHA, most would favor rather than oppose fluoridation (63% vs. 11%).
  • Americans are much more confident that the American Dental Association, or ADA, is providing trustworthy information about the health effects of fluoride in drinking water than HHS Secretary Robert F. Kennedy Jr. (74% to 34%). Among MAHA supporters, there is greater confidence in Kennedy (74%) but also confidence in the ADA (68%).

About a quarter (26%) of respondents in our nationally representative survey sample consider themselves supporters of the MAHA movement, or Make America Healthy Again, the political slogan and health initiative first associated with RFK Jr.’s 2024 presidential campaign. Another 40% do not consider themselves MAHA supporters and 33% are not sure. For this analysis we look at responses from the total population, self-identified MAHA supporters, and self-identified non-supporters of MAHA. (Download the topline.)

“Americans are divided on fluoridation, but what stands out is that supporters of the Make America Healthy Again movement are notably more skeptical,” said Patrick E. Jamieson, director of APPC’s Annenberg Health and Risk Communication Institute, which oversees this survey. “Even so, there is widespread trust in the American Dental Association, which reports that 80 years of research shows community water fluoridation to be safe and ‘the single most effective public health measure to prevent tooth decay.’”

Familiarity with use of fluoride in U.S. water supplies

Though fluoride has been part of water supplies across the United States for decades, many Americans say they are not familiar with this. Nearly half of U.S. adults (46%) say they are not familiar with the use of fluoride in U.S. water supplies, while 54% say they are somewhat (45%) or very familiar (9%) with it. Four in 10 (41%) people are not sure whether their community’s public water supply is fluoridated, while about half (48%) say their community’s is.

Perceived effects of water fluoridation on public health

By more than a 2-1 margin, Americans say the use of fluoride in public water supplies has an overall positive (42%) rather than a negative (17%) effect on public health, while 6% say it has no effect. Yet over a third (35%) are not sure, which could reflect a lack of familiarity with the use of fluoride in water supplies.

MAHA supporters are four times more likely than non-supporters to say fluoride in the water supplies has a negative effect on public health (30% vs. 7%). Non-MAHA supporters are twice as likely as MAHA supporters to say water fluoridation has a positive effect on public health (61% vs 30%).

“Although MAHA supporters favor public water fluoridation less than other groups, MAHA supporters are surprisingly equally likely to say fluoride has a positive effect on public health as a negative effect – 30% in both cases – reflecting their uncertainty about its effects,” said Laura A. Gibson, an APPC research analyst.

Views on fluoridating public water supplies

Asked to choose which among a variety of views on fluoridating public water supplies is closest to their own, in the overall population more people support community fluoridation (43%) than oppose it (22%), while a third (34%) don’t have an opinion:

  • Among supporters of fluoridation, there is a close divide between those who support fluoridation as a community decision (23%) and those who think communities should be required to fluoridate public water (20%).
  • Among opponents of fluoridation, there is an even split between those who think all communities should be banned from fluoridating (11%) and those who oppose fluoridation but think the decision should be left up to each community (11%).

MAHA supporters are more likely to oppose fluoridation, while non-supporters are more clearly in favor of fluoridation:

  • Among MAHA supporters, 21% oppose fluoridation and think communities should be banned from doing so, and 18% oppose it but agree the decision should be left up to the community.
  • Among non-supporters of MAHA, 33% express support for mandated fluoridation and 28% say they are supportive of fluoridation but think the decision to do so should be left up to each community.

Policy positions on ending the use of fluoride in public water supplies

A plurality of respondents oppose a policy to end the use of fluoride in public drinking water (40% vs. 28% favoring). A third (32%) indicate they neither favor nor oppose. MAHA supporters are over three times as likely to say they favor ending the use of fluoride in drinking water than non-supporters of MAHA (50% vs. 15%).

Who is more trustworthy on fluoridating water: RFK Jr. or the ADA?

Overall, the American public is much more confident that the American Dental Association (ADA) is providing the public with trustworthy information about the health effects of fluoride in drinking water than HHS Secretary Robert F. Kennedy Jr.

The survey finds that two-thirds of U.S. adults (65%) are not confident Kennedy is providing trustworthy information on fluoride in drinking water, with 42% who are “not at all confident” and 23% who are “not too confident.” Only a third of adults (34%) are confident in Kennedy, with 8% who are “very confident” and 27% “somewhat confident.”

By contrast, three-quarters of U.S. adults (74%) say they are confident in the ADA, with 28% who are very confident and 45% who are somewhat confident. A quarter of those surveyed (26%) are not confident in the ADA, with 9% who are not at all confident and 17% who are not too confident.

Among the subgroup of MAHA supporters, confidence in Kennedy is much higher. Three in four (74%) MAHA supporters are very (23%) or somewhat (51%) confident in him as a trustworthy source of information about fluoride’s health effects, while only 9% of non-MAHA supporters say they are confident in the health secretary.

The general public and non-supporters of MAHA show greater levels of confidence in the ADA than Kennedy to provide trustworthy information about the health effects of fluoride in drinking water. While most MAHA supporters also express confidence in the ADA (68%), more voice confidence in Kennedy (74%) – and people who are not MAHA supporters have even greater confidence in the ADA (83%).

“When it comes to fluoride, Americans place considerably more trust in the American Dental Association than in Health Secretary Robert F. Kennedy Jr.,” said Ken Winneg, APPC’s managing director of survey research. “These overall numbers obscure the finding that many MAHA supporters express confidence in both sources, reflecting how differently Americans evaluate health information depending on their broader views.”

APPC’s ASAPH survey

The findings come from Wave 29 of the Annenberg Science and Public Health survey (ASAPH), conducted April 14-28, 2026, among 1,639 U.S. adults. It was conducted for the policy center by SSRS, an independent research company. The nationally representative probability-based panel, first empaneled in April 2021, has a margin of sampling error of ± 3.5 percentage points at the 95% confidence level. All figures are rounded to the nearest whole number and may not add to 100%. Combined subcategories may not add to totals in the topline and text due to rounding.

Download the topline and methodology report.

The policy center has been tracking the American public’s knowledge, beliefs, and behaviors regarding vaccination, Covid-19, flu, RSV, and other consequential health issues through the Annenberg Science and Public Health (ASAPH) survey and separate national samples since April 2021. The ASAPH survey is conducted under the auspices of APPC’s Annenberg Health and Risk Communication Institute (AHRCI) by a team that includes Ken Winneg, managing director of survey research; research analysts Laura A. Gibson and Shawn Patterson Jr.; and Patrick E. Jamieson, director of the Annenberg Health and Risk Communication Institute.


Confidence in the American Dental Association vs RFK Jr 

Annenberg Science and Public Health (ASAPH) Survey Apr. 2026, N=1639, MOE=+/-3.5%

Credit

Annenberg Public Policy Center


See other recent Annenberg health survey news releases:

The Annenberg Public Policy Center was established in 1993 to educate the public and policy makers about communication’s role in advancing public understanding of political, science, and health issues at the local, state, and federal levels. Connect with us on Facebook, X, Instagram, and Bluesky.



Poll: Trust in CDC has fallen dramatically in the last year




Harvard T.H. Chan School of Public Health

 




Boston, MA—A year after changes to federal leadership in the U.S. public health system, a new poll finds that trust in public health agencies has dropped dramatically. Only 50% of U.S. adults say they trust health recommendations from the Centers for Disease Control and Prevention (CDC), compared to 77% in spring 2025. The fraction who say they trust their state health department has declined from 80% to 66% and the fraction who say they trust their local public health department has fallen from 82% to 70%.

The poll, One Year In: Public Views of a Changing Public Health Landscape, was conducted by Harvard T.H. Chan School of Public Health and the de Beaumont Foundation’s Public Health Listening Lab from March 19 to April 1, 2026, among a probability-based, nationally representative sample of 2,205 U.S. adults ages 18+. The poll was supported by the de Beaumont Foundation.

Trust in public health agencies takes a tumble

Trust in CDC health recommendations remained relatively stable in the wake of the COVID-19 pandemic but has fallen precipitously in the last year. Trust hovered around 75% from 2022 to 2025; a year into new federal leadership, it declined to 50%. The fraction of the public saying they trust CDC health recommendations includes about a third (38%) who say they trust them “somewhat” and a small share (12%) who say they trust them “a great deal.”

This decline in trust is driven by deep partisan divides. From 2025 to 2026, trust in CDC health recommendations has fallen from 92% to 34% among Democrats and from 77% to 47% among Independents. This steep drop also translates to losses in trust across demographic groups. Trust in the CDC has fallen more than 30 percentage points among women (80% to 48%); Black and Hispanic adults (77% to 43% and 81% to 50% respectively); those living in urban areas (80% to 48%); and those with a college degree (80% to 46%). Meanwhile, trust among Republicans has increased very slightly, from 63% to 67%.

“The link between political affiliation and trust in public health institutions is worrisome and doesn’t bode well for the future,” said Brian C. Castrucci, president and CEO of the de Beaumont Foundation. “Decision makers can and will have differing views on the best policy solutions to public health challenges, but it’s important for them to be grounded in a common set of facts. Science should not be a point of view. Once facts are politicized, it becomes increasingly difficult to bridge the divide.”

Trust in state and local public health agencies has also fallen in the last year, but not as dramatically. Between 2025 and 2026, trust in state public health agencies dropped from 80% to 66%, while trust in local public health agencies dropped from 82% to 70%. State and local health departments are now substantially more trusted than federal agencies such as the CDC (50%) or the U.S. Food and Drug Administration (FDA) (53%).

Approval of federal public health agencies’ actions falls along party lines

A slim majority (55%) of the U.S. public disapproves of federal public health agencies’ actions in the past year, with disapproval strongly linked to partisan identity. Most Democrats (86%) disapprove, but only one in five Republicans (20%) say the same.

Top concerns about federal health agencies’ actions under new leadership include wide agreement from the public that their recommendations were too influenced by leaders’ personal beliefs (68%) or focused too much on the wrong priorities (66%). About six in ten agree that agencies have cut or scaled back programs too much (61%), made too many decisions without following standard processes (60%), and cut or scaled back government funding for health or medical research too much (60%).

There is less public agreement with neutral and positive statements regarding federal health agencies’ actions. Less than half agree that agencies have put decisions back in the hands of families (46%) or have been trying to do the right thing (44%). Only about a third agree that federal health agencies have made recommendations that follow the best available scientific evidence (38%), have had a positive impact on the health of average Americans (37%), or have represented the interests of people like them (35%).

Support for childhood vaccination remains strong across party lines, but may be softening

A year into new federal public health leadership, there is still strong majority support for routine childhood vaccination requirements. More than three-quarters (77%) of the public say that parents should be required to vaccinate their children in order to attend school, which has been nearly the same since the COVID-19 pandemic (range of 74% to 79% between 2021 and 2025). Though there are differences in vaccine support by political party, notable majorities of both parties – 91% of Democrats and 65% of Republicans – say that parents should be required to vaccinate their children in order to attend school.

Nonetheless, there are some indications that vaccine support may be softening. While a majority of U.S. adults (58%) oppose reducing the childhood vaccine schedule, which forms the basis of childhood vaccine requirements, there is substantial minority support (42%) for this policy change. Nearly two-thirds of Republicans (65%) support reducing the childhood vaccine schedule, compared to fewer than one in five Democrats (18%).  

Another indication of possible softening vaccine support comes from a slight dip in the fraction of people saying that childhood vaccines are safe. Overall views on childhood vaccine safety are high at 89%, but have declined slightly from 94% during the peak of the COVID-19 pandemic (2021–2022). This overall decline includes a decrease in the fraction of the public saying childhood vaccines are “very safe,” which now stands at 57%, down from a high of 70% during the peak of COVID-19. Strong shares of adults in both parties say vaccines are safe overall, with 85% of Republicans and 96% of Democrats saying childhood vaccines are “very safe” or “somewhat safe,” but there is a wide gap in the subset saying vaccines are “very safe” (46% of Republicans versus 76% of Democrats).  

“Social media and news coverage tend to elevate the loudest voices that question or outright oppose vaccines, so it can often feel like there is a rise in anti-vaccine sentiment amongst the general public. The reality is that the vast majority of people support vaccines for children and believe they are safe,” said Gillian K. SteelFisher, survey lead and principal research scientist at Harvard Chan School. “That said, it is true that many families are questioning the necessity of vaccines and weighing what vaccine requirements mean for their parental authority. Healthcare providers and public health communicators need to be able to address these concerns with empathy and compassion.” 

Strong support for changes to the food pyramid, but partisan patterns persist at a high level

A majority of the public (60%) supports the recent changes to the food pyramid and the Dietary Guidelines for Americans, and even stronger majorities support specific measures, including recommendations to avoid or sharply limit sugar and highly-processed food (90%) and recommendations to increase protein intake (85%). A smaller majority (62%) supports recommendations to increase beef and whole milk consumption.

Support is bipartisan for limiting sugar and highly-processed food (Republicans: 94%, Democrats: 89%) and for increasing protein intake (Republicans: 92%, Democrats: 79%). But there is partisan division when considering support for overall changes: 83% of Republicans say they support changes to the food pyramid, compared to only 37% of Democrats. Support for recommendations to increase beef and whole milk consumption is also divided, with 80% support among Republicans and 44% support among Democrats.

See the poll report for full findings and topline.

Methodology

Results are based on survey research conducted by the Harvard Opinion Research Program (HORP) based at Harvard T.H. Chan School of Public Health, in partnership with the de Beaumont Foundation. Representatives from these organizations developed the survey questionnaire, while analyses were conducted by researchers from Harvard Chan School and the fielding team at SSRS of Glen Mills, Pennsylvania. 

The HORP project team included Gillian SteelFisher, director of HORP and principal research scientist at Harvard Chan School, and Mary Findling, managing director of HORP.

The de Beaumont Foundation project team included Brian C. Castrucci, president and CEO of the de Beaumont Foundation, Emma Prus, senior program and research associate, and Nalini Padmanabhan, communications director.

Interviews were conducted with a representative sample of 2,205 U.S. adults ages 18 and older. Interviews were conducted in English and Spanish online and by telephone. Respondents were reached online and by phone through the SSRS Opinion Panel, a nationally representative, probability-based panel. Panelists were randomly recruited via an Address Based Sampling frame and from random-digit dial samples on SSRS surveys. Most panelists completed the survey online with a small subset who do not access the internet completing by phone. The interview period was March 19 to April 1, 2026.

Findings and conclusions are those of the authors and do not necessarily represent the official position of the de Beaumont Foundation or Harvard Chan School. When interpreting findings, one should recognize that all surveys are subject to sampling error. Results may differ from what would be obtained if the whole U.S. adult population had been interviewed. The margin of error at the 95% confidence interval is +2.0 percentage points.

Republicans include adults who lean Republican, Democrats include adults who lean Democrat, and Independents include adults who identify as “other” or are unaffiliated. Trend data in this poll is compared to the following prior polls of U.S. adults ages 18 and older: 2025 Harvard T.H. Chan School of Public Health/de Beaumont Foundation (n=3,343); 2019, 2021, 2022, and 2023 polls of U.S. adults ages 18 and older, conducted by Harvard T.H. Chan School of Public Health/Association of State and Territorial Health Officials (ASTHO)/National Public Health Information Coalition (NPHIC) (Nov 2023 n=1632; July 2023 n=1430; Nov 2022 n=1,813; Feb 2022 n=4208; 2021 n=2,500; 2019 n=1,550). Possible sources of non-sampling error include non-response bias, as well as question wording and ordering effects. Non-response in web and telephone surveys produces some known biases in survey-derived estimates because participation tends to vary for different subgroups of the population. To compensate for these known biases and for variations in the probability of selection within and across households, sample data are weighted in a multi-step process by probability of selection and recruitment, response rates by survey type, and demographic variables (gender, age, education, race/ethnicity, region, the frequency of internet use, civic engagement, population density, registered voter, party ID, religious affiliation, number of adults in household, and home tenure) to reflect the true population of adults in the U.S. Other techniques, including random sampling, multiple contact attempts, replicate subsamples, and systematic respondent selection within households, are used to ensure that the sample is representative.

Visit the Harvard Chan School website for the latest news and events from our Studio.

For more information:

Maya Brownstein
mbrownstein@hsph.harvard.edu

Nalini Padmanabhan
media@debeaumont.org

###

Harvard T.H. Chan School of Public Health is a community of innovative scientists, practitioners, educators, and students dedicated to improving health and advancing equity so all people can thrive. We research the many factors influencing health and collaborate widely to translate those insights into policies, programs, and practices that prevent disease and promote well-being for people around the world. We also educate thousands of public health leaders a year through our degree programs, postdoctoral training, fellowships, and continuing education courses. Founded in 1913 as America’s first professional training program in public health, the School continues to have an extraordinary impact in fields ranging from infectious disease to environmental justice to health systems and beyond.

The de Beaumont Foundation creates and invests in bold solutions that improve the health of communities across the country. Its mission is to advance policy, build partnerships, and strengthen public health to create communities where everyone can achieve their best possible health. For more information, visit www.debeaumont.org.

 

New study shows metformin given during acute COVID-19 infection reduced risk of clinician-diagnosed long COVID by 50%



University of Minnesota Medical School





MINNEAPOLIS/ST. PAUL (6/11/2026) — New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.

The study, published in Clinical Infectious Diseases and co-led by a University of Minnesota Medical School research team, evaluated nearly 3,000 outpatient adults with mild-to-moderate COVID-19 across 90 sites in the United States. Participants were randomized to receive either metformin or placebo within seven days of symptom onset and were followed for six months.

At six months, participants who received metformin experienced a 50% relative reduction in the risk of clinician-diagnosed long COVID compared with those receiving placebo, indicating that metformin cut the risk of a medical diagnosis of long COVID by approximately half.

Among participants followed through 180 days, clinician-diagnosed long COVID occurred in 0.56% of those receiving metformin compared with 1.17% of those receiving placebo.

"This trial provides additional evidence that treating acute infection with this intervention that acts on metabolic health can reduce the likelihood of developing long COVID," said Carolyn Bramante, MD, MPH, assistant professor at the University of Minnesota Medical School, internist and pediatrician with M Health Fairview and lead author of the study. "The finding is particularly important because metformin is inexpensive, globally available and has decades of clinical use supporting its safety."

As a National Center for Advancing Translational Sciences (NCATS)-funded CTSI Scholar, Dr. Bramante developed a program to study metformin as an outpatient treatment for acute SARS-CoV-2 because of its history as an anti-viral in the early 1900s and because of its known anti-inflammatory actions.

The ACTIV-6 trial enrolled adults considered to be low, standard, or high risk between September 2023 and May 2024 during a period when most participants already had substantial immunity from prior vaccination, prior infection or both. More than 83% of participants had evidence of prior partial immunity, making the results highly relevant to the current phase of the pandemic.

While the trial's primary endpoint — responding yes to having any COVID-19 symptoms on Day 180 after starting the trial — did not meet the pre-specified threshold for efficacy, metformin consistently favored improved long-term outcomes. Investigators observed a high probability of benefit for reducing symptom burden and preventing clinician-diagnosed long COVID. Additionally, no safety concerns emerged during the study.

The findings replicate results from the earlier University of Minnesota-led COVID-OUT randomized trial, which reported a similar reduction in long COVID among participants treated with metformin during acute infection. 

“Reproducing research is very important, and both trials have also been replicated in analyses of electronic health record data. Together, these independent studies support that in low- to high-risk adults, metformin is an effective strategy to reduce the risk of long COVID,” said David Boulware, MD, MPH, professor at the University of Minnesota Medical School, infectious disease physician with M Health Fairview and steering committee co-chair of the trial.  

Next steps in this research include looking at biospecimens taken during acute infections and seeing if similar actions exist during other infections. 

This research was funded by NCATS.

###

About the University of Minnesota Medical School
The University of Minnesota Medical School is at the forefront of learning and discovery, transforming medical care and educating the next generation of physicians. Our graduates and faculty produce high-impact biomedical research and advance the practice of medicine. We acknowledge that the U of M Medical School is located on traditional, ancestral and contemporary lands of the Dakota and the Ojibwe, and scores of other Indigenous people, and we affirm our commitment to tribal communities and their sovereignty as we seek to improve and strengthen our relations with tribal nations. Learn more at med.umn.edu.

About ACTIV-6

ACTIV-6 (Accelerating COVID-19 Therapeutic Interventions and Vaccines) is a nationwide, randomized, placebo-controlled platform trial designed to evaluate repurposed medications for the treatment of COVID-19. The study was supported by the National Center for Advancing Translational Sciences (NCATS).